 |
Article Review/Hyperlink |
Braun S, Boyko V, Behar S, et al for the Bezafibrate Infarction Prevention Study Participants
Calcium antagonists and mortality in patients with coronary artery disease: A cohort study of 11,575 patients
J Am Coll Cardiol (Jul) 28:7-11 1996
The controversy about the safety of calcium channel blockers in hypertension, especially of short acting dihydropyridine drugs such as short-acting nifedipine, continues to simmer, although now the pendulum seems to have swung back to the point that the validity of the original studies by Furberg are being challenged (see https://www.hdcn.com/newsal.htm#nws9195).
This paper found no increased mortality risk associated with short-acting dihydropyridine drugs in patients with coronary artery disease. (John T. Daugirdas, M.D., University of Illinois at Chicago)
The full text of this article is available from the ACC at:
this site .
| Related Folders: |
|
|
